The Effect of Artificial Sweeteners on Blood Glucose Response

May 17, 2012 updated by: Northumbria University
The purpose of this study is to determine whether the presece of the artificial sweeteners aspartame, saccharin and asceulfame-k affect the blood glucose responses to an orally incested glucose solution.

Study Overview

Detailed Description

Sweet taste receptors, similar to those located on the lingual taste buds have been located along in the lining of the gut. Recent studies have demonstrated that activation of these sweetness taste receptors, either by sugars such as glucose, fructose, lactose, or artificial sweeteners such as saccharin and aspartame can influence the way nutrients, including glucose are absorbed from the gut into the bloodstream. Studies in animal models have shown that activation of the sweet taste receptors can increase the expression of the sodium-dependant glucose transporter 1 (SGLT1) and glucose transporter 2 (GLUT2) which transport glucose from the lumen into the bloodstream. Thus providing a potential mechanism by which glucose uptake can be regulated. Although artificial sweeteners stimulate the sweet taste receptors, they have little nutritive value, so that when they are consumed in the absence of any other nutrients there is little effect on blood glucose response. However, the effects of consuming artificial sweeteners in combination with sugars such as glucose is unclear. The purpose of this study is to investigate whether the addition of artificial sweeteners to an orally consumed glucose solution affects the rate at which the glucose appears in the blood.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Newcastle-Upon Tyne, United Kingdom, NE1 8ST
        • Brain, Performance and Nutrition Research Centre- Northumbria University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy subjects
  • Aged 18-45 years
  • BMI (19-25 kg/m2)
  • Weight stable in past 3 months

Exclusion Criteria:

  • Smoking
  • Females who are pregnant of breastfeeding
  • Regular intake of emdication, other than females taking oral contraceptives
  • Medical illness
  • Gastrointestinal disorders
  • Food allergies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: 45g glucose
glucose water
A 400mL drink sweetened with 45g glucose and artificial sweetener will be consumed orally
Active Comparator: 45g glucose + 150mg aspartame
glucose water aspartame
A 400mL drink sweetened with 45g glucose and artificial sweetener will be consumed orally
Active Comparator: 45g glucose + 20 mg saccharin
glucose water saccharin
A 400mL drink sweetened with 45g glucose and artificial sweetener will be consumed orally
Active Comparator: 45g glucose + 85mg asculfame - K
glucose water aseulfame- k
A 400mL drink sweetened with 45g glucose and artificial sweetener will be consumed orally

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood glucose response
Time Frame: 90 min
Blood glucose will be determined at baseline and for 90 min following the consumption of the test drinks
90 min

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective appetite
Time Frame: 90 min
Subjective appetite ratings will be collected at baseline and for 90 min following the consumption of the test drinks
90 min

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nerys M Astbury, PhD, Northumbria University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2010

Primary Completion (Anticipated)

May 1, 2011

Study Completion (Anticipated)

May 1, 2011

Study Registration Dates

First Submitted

November 22, 2010

First Submitted That Met QC Criteria

November 22, 2010

First Posted (Estimate)

November 23, 2010

Study Record Updates

Last Update Posted (Estimate)

May 18, 2012

Last Update Submitted That Met QC Criteria

May 17, 2012

Last Verified

May 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • 34AK1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Glucose

Clinical Trials on Artificial Sweeteners

3
Subscribe